Top Section/Ad
Top Section/Ad
Most recent
BWICs spike and spreads widen but market remains constructive
Resets and refis prominent in pipeline as loan market softens, offering respite from repricing wave
Dasha Sobornova joins from Akin Gump with experience across asset classes
Trade body for levfin investors turns to leading rating analyst
More articles/Ad
More articles/Ad
More articles
-
Valeant Pharmaceuticals, the largest obligor across US CLOs, announced a loss for the second quarter on Tuesday, but its CEO reassured investors and lenders that the plan for a turnaround is still on track. -
The US CLO market is reaping the benefits of newly enriched investors hunting yield following the $8.5bn Countrywide RMBS settlement, sources told GlobalCapital.
-
Corporate indebtedness in the US continues to be a focus for regulators, financiers and CLO investors, following the release of the 2016 Shared National Credit (SNC) review earlier this month.
-
Top tier US CLO managers maintained their hold on the market in the first six months of 2016, with the list of top managers holding steady year over year.
-
US CLO triple-A spreads are on a tear, with the latest offering tightening below the 150bp mark for the first time in 2016, buoyed by a broadening investor base and improved market sentiment.
-
Société Générale this week appointed a new European head of leveraged loan syndicate, after the former levloan boss left the bank.
